Farmachem Life Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 29-07-2024
- Paid Up Capital ₹ 1.92 Cr
as on 29-07-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.20 Cr
as on 29-07-2024
- Satisfied Charges ₹ 11.75 Cr
as on 29-07-2024
- Revenue -7.45%
(FY 2023)
- Profit -72.31%
(FY 2023)
- Ebitda -69.91%
(FY 2023)
- Net Worth 10.97%
(FY 2023)
- Total Assets -2.40%
(FY 2023)
About Farmachem Life
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.92 Cr.
The company currently has active open charges totaling ₹30.20 Cr. The company has closed loans amounting to ₹11.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Narendra Zota and Raksha Zota serve as directors at the Company.
- CIN/LLPIN
U51496MH2008PTC180172
- Company No.
180172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Farmachem Life Private Limited offer?
Farmachem Life Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Farmachem Life?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Zota  | Director | 17-Mar-2008 | Current |
| Raksha Zota | Director | 17-Mar-2008 | Current |
Financial Performance of Farmachem Life.
Farmachem Life Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.45% decrease. The company also saw a substantial fall in profitability, with a 72.31% decrease in profit. The company's net worth Soared by an impressive increase of 10.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Farmachem Life?
In 2022, Farmachem Life had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2024 | ₹10.00 Cr | Open |
Hdfc Bank Limited Creation Date: 22 Jul 2022 | ₹2.20 Cr | Open |
Citi Bank N.A. Creation Date: 28 Sep 2018 | ₹18.00 Cr | Open |
How Many Employees Work at Farmachem Life?
Unlock and access historical data on people associated with Farmachem Life, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Farmachem Life, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farmachem Life's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
